INBS

Intelligent Bio Solutions Inc.

INBS.US ibs.inc + Research + Basket
CIK 0001725430
Employees 59
Phone 646 828 8258
Fiscal year end June
IPO Dec 23, 2020
Address 135 West, 41st Street, New York, NY, United States, 10036
1.69
-0.03 (-1.68%)
USD · NASDAQ
52-week range
1.35
24.90
Trading at 1% of the 52-week range
Market Cap
5.70M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
1.90
Div. Yield
N/A
% Institutions
5.47%
% Insiders
2.73%

1 Year

-82.8%

3 Year

-93.8%

10 Year

-100.0%
Description

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Actions

Add an action for INBS.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Harry Simeonidis President & CEO 1968
Mr. Spiro Kevin Sakiris B.Bus, C.A., Dip Law Chief Financial Officer 1962
Callistus Sequeira Vice President of Global Quality & Operations NA
Mr. Doug Heath Vice President of Global Sales NA
Anna Turkington Vice President of Marketing NA
Mr. Valter Pinto Managing Director of KCSA Strategic Communications NA
Mr. Peter Passaris Vice President of Product Development NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Aug 31, 2023 Harry Simeonidis N/A Purchase N/A $230.40 N/A SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Armistice Capital, LLC 141.40K Jun 30, 2026 4.26% $0.00 8.77%
Geode Capital Management, LLC 20.84K Jun 30, 2026 0.63% $0.00 -27.16%
Vanguard Capital Management, LLC 5.81K Jun 30, 2026 0.18% $0.00 0.00%
UBS Group AG 5.74K Jun 30, 2026 0.17% $0.00 1,441.67%
Vanguard Fiduciary Trust Co 3.96K Jun 30, 2026 0.12% $0.00 0.00%
Tower Research Capital LLC 3.28K Jun 30, 2026 0.10% $0.00 162.40%
Advisor Group Holdings, Inc. 200.00 Jun 30, 2026 0.01% $0.00 0.00%
Barclays PLC 142.00 Jun 30, 2026 0.00% $0.00 0.00%
SHP Wealth Management 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
CURIO WEALTH, LLC 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Citigroup Inc 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
NATIONAL BANK OF CANADA /FI/ 0.00 Mar 31, 2026 0.00% $0.00 -100.00%
Alyeska Investment Group, L.P. 0.00 Jun 30, 2026 0.00% $0.00 -100.00%
Bank of America Corp 0.00 Mar 31, 2026 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity Extended Market Index 12.48K 0.38% ▼ 0.53% Aug 31, 2026
2 Fidelity Nasdaq Composite Index 2.54K 0.08% ▲ 0.00% Aug 31, 2026
3 Fidelity Series Total Market Index 1.77K 0.05% ▲ 0.00% Aug 31, 2026
4 Fidelity Total Market Index 409.00 0.01% ▲ 0.00% Aug 31, 2026

Financial Highlights

▼
Market Cap: $5.70M
EBITDA: $-11.15M
Book Value: $1.90
Earnings/Share: $-8.44
Profit Margin: -294.91%
Operating Margin: -345.98%
ROA (TTM): -76.20%
ROE (TTM): -307.69%
Revenue (TTM): $4.22M
Revenue/Share (TTM): $2.86
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 35.80%

Valuation Metrics

Enterprise Value: $3.27M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 3.32M
Shares Float: 2.94M
% Insiders: 2.73%
% Institutions: 5.47%
Short % Float: 1.81%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$4.22M
Cost of Goods Sold
adjust
$-2.17M
Gross Profit
subtotal
$2.05M
SG&A
adjust
$-10.50M
R&D
adjust
$-3.37M
Other Operating Expense
adjust
$-784.63K
Operating Income
subtotal
$-12.61M
Other / Non-Operating Items
adjust
$177.11K
Net Income
subtotal
$-12.43M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about INBS.US!